Affiliation:
1. KIIT University, India
2. Ho Chi Minh City University of Medicine and Pharmacy Hospital, Ho Chi Minh City, Vietnam
Abstract
In the post-COVID-19 era, machine learning is reshaping healthcare by advancing precision medicine. This study explores the impact of ML applications on disease analysis, patient care, and risk prediction. Through extensive literature review and bibliometric analysis, the authors uncover global trends and collaborations, highlighting prolific contributions from countries like the U.S., China, and the U.K. Ethical considerations and challenges are addressed, emphasizing the potential of ML-powered precision medicine to transform diagnostics, treatment, and patient outcomes in a collaborative and responsible manner. In the dynamic landscape of post-COVID-19 healthcare, the imperative for smart healthcare solutions and precision medicine systems has intensified.
Reference17 articles.
1. Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning
2. Deep learning for computational biology
3. Bains, W. (2004). Failure rates in drug discovery and development. Drug Discovery, 9. https://www.ddw-online.com/media/32/04.fal.failure-rates-in-drug-discovery-and-development---will-we-ever-get-any-better.pdf
4. A (Very) Brief History of Artificial Intelligence.;G. B.Bruce;Genomics,2005
5. Artificial intelligence, bias and clinical safety